Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1963 Aug;47(8):469–484. doi: 10.1136/bjo.47.8.469

PHOSPHOLINE IODIDE (217 M 1) (ECOTHIOPHATE IODIDE) IN THE TREATMENT OF GLAUCOMA*

J P F Lloyd 1
PMCID: PMC505833  PMID: 14189715

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKER B., GAGE T. Demecarium bromide and echothiophate iodide in chronic glaucoma. Arch Ophthalmol. 1960 Jan;63:102–107. doi: 10.1001/archopht.1960.00950020104015. [DOI] [PubMed] [Google Scholar]
  2. BECKER B., PYLE G. C., DREWS R. C. The tonographic effects of echothiophate (phospholine) iodide: reversal by pyridine-2-aldoxine methiodide (P2AM). Am J Ophthalmol. 1959 May;47(5 Pt 1):635–640. doi: 10.1016/s0002-9394(14)78187-5. [DOI] [PubMed] [Google Scholar]
  3. CALLAHAN A. Use of di-isopropyl fluorophosphate in 0.01-percent and 0.025-percent concentrations. Am J Ophthalmol. 1957 Feb;43(2):281–283. doi: 10.1016/0002-9394(57)92924-0. [DOI] [PubMed] [Google Scholar]
  4. COYLE J. T., WEINER A., FRANK P., LEONARD A. The management of glaucoma in the indigent clinic patient with echothiophate iodide. Am J Ophthalmol. 1961 Dec;52:867–871. doi: 10.1016/0002-9394(61)90330-0. [DOI] [PubMed] [Google Scholar]
  5. KOELLE G. B., STEINER E. C. The cerebral distributions of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection. J Pharmacol Exp Ther. 1956 Dec;118(4):420–434. [PubMed] [Google Scholar]
  6. KRISHNA N., LEOPOLD I. H. Echothiophate (phospholine) iodide (217-MI) in treatment of glaucoma; further observations. AMA Arch Ophthalmol. 1959 Aug;62(2):300–313. doi: 10.1001/archopht.1959.04220020126019. [DOI] [PubMed] [Google Scholar]
  7. LEHMAN R. A., FITCH H. M., BLOCHI L. P., JEWELL H. A., NICHOLLS M. E. Antidotes and potentiating agents for phospholine iodide. J Pharmacol Exp Ther. 1960 Mar;128:307–317. [PubMed] [Google Scholar]
  8. LEHMAN R. A., NICHOLLS M. E. Antagonism of phospholine (echothiophate) iodide by certain quaternary oximes. Proc Soc Exp Biol Med. 1960 Aug-Sep;104:550–554. doi: 10.3181/00379727-104-25904. [DOI] [PubMed] [Google Scholar]
  9. LEOPOLD I. H., GOLD P., GOLD D. Use of a thiophosphinyl quaternary compound (217-MI) in treatment of glaucoma. AMA Arch Ophthalmol. 1957 Sep;58(3):363–366. doi: 10.1001/archopht.1957.00940010375007. [DOI] [PubMed] [Google Scholar]
  10. MAMO J. G., LEOPOLD I. H. Evaluation and use of oximes in ophthalmology. Am J Ophthalmol. 1958 Nov;46(5 Pt 1):724–731. doi: 10.1016/0002-9394(58)91271-6. [DOI] [PubMed] [Google Scholar]
  11. SACKS-WILNER A., SACKS-WILNER E. Glaucoma therapy with echothiophate (phospholine iodide). Am J Ophthalmol. 1961 Apr;51:695–698. doi: 10.1016/0002-9394(61)91615-4. [DOI] [PubMed] [Google Scholar]
  12. SCHAUMANN W., JOB C. Differential effects of a quaternary cholinesterase inhibitor, phospholine, and its tertiary analogue, compound 217-AO, on central control of respiration and on neuromuscular transmission: the antagonism by 217-AO of the respiratory arrest caused by morphine. J Pharmacol Exp Ther. 1958 Jun;123(2):114–120. [PubMed] [Google Scholar]
  13. SCHILD H. O. Drug antagonism and pAx. Pharmacol Rev. 1957 Jun;9(2):242–246. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES